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PAtrial Fibrillation
Obstructive Sleep Apnea, Obesity,
and the Risk of Incident Atrial Fibrillation
Apoor S. Gami, MD,*† Dave O. Hodge, MS,‡ Regina M. Herges, BS,‡ Eric J. Olson, MD,†§
Jiri Nykodym, BS,*† Tomas Kara, MD,*† Virend K. Somers, MD, PHD, FACC*†
Rochester, Minnesota
Objectives This study sought to identify whether obesity and obstructive sleep apnea (OSA) independently predict incident
atrial fibrillation/flutter (AF).
Background Obesity is a risk factor for AF, and OSA is highly prevalent in obesity. Obstructive sleep apnea is associated with
AF, but it is unknown whether OSA predicts new-onset AF independently of obesity.
Methods We conducted a retrospective cohort study of 3,542 Olmsted County adults without past or current AF who were
referred for an initial diagnostic polysomnogram from 1987 to 2003. New-onset AF was assessed and con-
firmed by electrocardiography during a mean follow-up of 4.7 years.
Results Incident AF occurred in 133 subjects (cumulative probability 14%, 95% confidence interval [CI] 9% to 19%). Uni-
variate predictors of AF were age, male gender, hypertension, coronary artery disease, heart failure, smoking,
body mass index, OSA (hazard ratio 2.18, 95% CI 1.34 to 3.54) and multiple measures of OSA severity. In sub-
jects 65 years old, independent predictors of incident AF were age, male gender, coronary artery disease, body
mass index (per 1 kg/m2, hazard ratio 1.07, 95% CI 1.05 to 1.10), and the decrease in nocturnal oxygen satura-
tion (per 0.5 U log change, hazard ratio 3.29, 95% CI 1.35 to 8.04). Heart failure, but neither obesity nor OSA,
predicted incident AF in subjects 65 years of age.
Conclusions Obesity and the magnitude of nocturnal oxygen desaturation, which is an important pathophysiological conse-
quence of OSA, are independent risk factors for incident AF in individuals 65 years of age. (J Am Coll Cardiol
2007;49:565–71) © 2007 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.08.060a
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itrial fibrillation/flutter (AF) is the most prevalent sus-
ained cardiac arrhythmia in the U.S. (1) and is associated
ith significant morbidity and mortality (2,3). In the U.S.,
he major clinical risk factors for AF include age, diabetes,
ypertension, heart failure, and coronary artery disease (4).
ong-term follow-up data of over 5,000 subjects in the
ramingham Heart Study (5) and nearly 48,000 subjects in
he Danish Diet, Cancer and Health Study (6) showed that
besity predicts AF independently of other clinical charac-
eristics. In the context of the growing obesity epidemic,
hese data have important implications for the population
urden of AF. They also raise the important question of
ow obesity leads to AF.
rom the *Division of Cardiovascular Diseases, †Department of Internal Medicine,
Department of Biostatistics, §Division of Pulmonary and Critical Care Medicine,
nd Division of Hypertension, Mayo Clinic College of Medicine, Rochester,
innesota. Dr. Somers is a consultant for Respironics, co-investigator for a study
unded with a grant from ResMed Foundation, and has received an honorarium from
esMed. The authors are funded by NIH grants HL61560, HL65176, HL73211,
nd M01-RR00585, and the Mayo Clinic.i
Manuscript received March 30, 2006; revised manuscript received August 22, 2006,
ccepted August 28, 2006.In a recent cross-sectional study, we showed a strong
ssociation between AF and obstructive sleep apnea (OSA),
ndependently of age, gender, hypertension, heart failure
nd, importantly, body mass index (7). No prior study,
ncluding the Framingham study and the Danish study, has
ssessed the potential contributions of OSA to the risk of
F associated with obesity. For several reasons, OSA may
ave an important role in clarifying the relationship between
besity and AF (8). First, obesity and OSA are powerfully
nd causally related (9). Second, pathophysiological charac-
eristics traditionally attributed to obesity have been shown
o be linked to occult OSA (10–14). Third, OSA is
ssociated with multiple pathophysiological mechanisms
hat may be directly implicated in the pathogenesis of AF
ither by triggering its initiation or by affecting the
yocardial substrate to promote or maintain the arrhyth-
ia. These mechanisms include repetitive and prolonged
ypoxemia, exaggerated intrathoracic pressure oscilla-
ions with increased cardiac wall stress (15–17), sympa-
hetic and parasympathetic imbalances (18), systemic
nflammation (14), and diastolic dysfunction (19 –22). It
s unknown, however, whether OSA increases the risk of
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OSA, Obesity, and AF February 6, 2007:565–71incident AF and how comorbid
conditions, including obesity,
may affect this relationship.
Methods
Study population. The Institu-
tional Review Board of the Mayo
Foundation approved the study,
and we only included individuals
who authorized their records to
e used for research. Data were collected from subjects’
edical records by dedicated and specifically trained per-
onnel in a cardiovascular research studies unit. Quality
ontrol of data collection was maintained by supervision and
eedback to the research personnel by a study physician. A
alidation series found excellent agreement between data of
subgroup of subjects collected blindly by both a study
hysician and the trained research personnel (Cohen kappa
.91) (23).
We identified adult residents of Olmsted County, Min-
esota, who underwent their first diagnostic polysomnog-
aphy at the Mayo Clinic Sleep Disorders Center from July
, 1987, to July 31, 2003. During these years, the Mayo
linic was the sole provider, in Olmsted County, of a
omprehensive sleep disorders evaluation, with initial con-
ultation by a sleep specialist, complete overnight polysom-
ography, study review with the sleep specialist, and long-
erm management of treatment when necessary. We
xcluded people with AF or a previous history of AF at the
ime of their first-ever polysomnogram because we wished
o assess the risk of incident AF after the initial diagnosis of
SA. Data were collected regarding demographics, anthro-
omorphic measurements, and relevant comorbid condi-
ions at the time of polysomnography for each subject.
lassification of OSA. All subjects’ sleep evaluations were
erformed at the Mayo Clinic Sleep Disorders Center, an
merican Academy of Sleep Medicine-accredited sleep
enter with real-time monitoring of polysomnography by
ertified sleep technicians and supervision by board-certified
leep specialists. Each evaluation consisted of consultation
ith a board-certified sleep physician and split-night poly-
omnography, in which the first half of the night is a
iagnostic study consisting of measurements of the electro-
ncephalogram, electro-oculogram, electromyogram, elec-
rocardiogram, thoracoabdominal excursions, pulse oxime-
ry, and naso-oral airflow. Physiological variables collected
rom the polysomnograms included sleep efficiency; arousal
ndex; the number of central apneas, obstructive or mixed
pneas, and hypopneas per hour of rapid eye movement and
on-rapid eye movement sleep; oxygen saturation during
akefulness; mean oxygen saturation during sleep; and the
owest oxygen saturation during sleep. Apneas and hypop-
eas were defined as obstructive events if occurring in the
resence of thoracoabdominal excursions representing ven-
Abbreviations
and Acronyms
AF  atrial
fibrillation/flutter
CI  confidence interval
HR  hazard ratio
OSA  obstructive sleep
apneailatory efforts, and the apnea-hypopnea index was calcu- iated as the average number of obstructive apneas and
ypopneas per hour of sleep. We defined OSA as an
pnea-hypopnea index 5 (24).
We ascertained the use of continuous positive airway
ressure therapy during follow-up. We considered that
ontinuous positive airway pressure had been used if it was
rescribed during the consultation with the sleep specialist
fter the sleep study and if a subsequent note in the medical
ecord stated that continuous positive airway pressure was
eing used.
lassification of AF. The occurrence of incident AF was
scertained from the date of polysomnography to the date of
eath or last follow-up (which was the date of the last clinic
isit, nursing home visit, emergency department visit, sur-
ical procedure, hospitalization, or laboratory evaluation) by
uerying the Mayo Clinic electronic medical index. The
ayo Clinic uses a unified medical record that includes the
etails of all inpatient and outpatient encounters, laboratory
eports, and correspondence for every patient (25). Diag-
oses made during office visits, clinic consultations, nursing
ome care, emergency department visits, surgical proce-
ures, hospitalizations, and autopsy examinations are listed
n a master sheet, assigned a modified hospital Interna-
ional Classification of Disease adaptation code, and in-
luded in a central, electronic, searchable diagnostic index
25). We cross-referenced our study sample with all medical
ndex diagnostic codes for acute, paroxysmal, and chronic
trial fibrillation; atrial fibrillation-flutter; and atrial flutter.
or quality assurance, we also manually reviewed the full
edical record of each subject with AF identified by the
bove methods. We established the occurrence of AF only
hen a study physician confirmed the diagnosis by review of
n electrocardiogram. We were interested in the occurrence
f incident AF, and thus did not assess the duration of AF
nd made no distinction between paroxysmal, persistent, or
ermanent AF. The collection of follow-up data and con-
rmation of AF were performed in a blinded fashion to the
ollection of polysomnographic data and the classification of
SA.
tatistical analysis. Characteristics of the study population
ere described by counts (with percentages) and means
with standard deviations) or medians (with interquartile
anges).
Time-to-event analyses were performed using Kaplan-
eier methods to identify univariate predictors of incident
F. The parameters included subject age, gender, body
ass index, relevant comorbidities, OSA status and severity,
nd physiological sleep variables. Multivariate time-to-event
nalyses were performed using Cox proportional hazards
egression methods. A stepwise selection technique was
sed to construct a clinical model with parameters that are
ell-established clinical predictors of AF, including age,
ender, smoking history, hypertension, diabetes, coronary
rtery disease, and heart failure. We also included body mass
ndex as a potential predictor in this model.
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February 6, 2007:565–71 OSA, Obesity, and AFTo assess the risk of AF posed by OSA and its related
leep parameters, we included these variables into the model
ndependently of one another: OSA status, OSA severity,
he apnea-hypopnea index, arousal index, awake oxygen
aturation, lowest nocturnal oxygen saturation, mean noc-
urnal oxygen saturation, and decrease in nocturnal oxygen
aturation (defined as the awake oxygen saturation minus
ean nocturnal oxygen saturation). Continuous variables
ith a non-Gaussian distribution were logarithmically
ransformed for analysis.
We tested for effect modification of the dependent variable
y interactions between OSA and gender or age by incorpo-
ating multiplicative interaction terms (OSA  gender and
SA age) into the regression models. The rationale for this
as the established increase of risk in men for both OSA
26) and AF (4), and the recognized nonmonotonic associ-
tion between OSA and cardiovascular morbidity and mor-
ality across the adult ages (27,28). Prior studies found that
ignificant relationships between OSA and cardiovascular
orbidity and mortality existed in adults through age 60 or
5 years, and then became nonsignificant in older patients
27,28). Thus, we performed multivariate analyses using
ox proportional hazards regression methods, as described
bove, to create additional models incorporating clinical
redictors and physiological sleep parameters for subjects
65 years of age and for subjects 65 years of age.
We performed an analysis that included only subjects
ith OSA to identify the effect of continuous positive
irway pressure use on the risk of incident AF. The use of
ontinuous positive airway pressure was introduced into a
ultivariate model, which was created as described above to
nclude the clinical predictors and sleep measurements. We
erformed an additional analysis to assess the simultaneous
ffects of both obesity and OSA, regardless of other comor-
idities, on incident AF by comparing the cumulative
robability of incident AF across 9 groups of subjects
haracterized by their apnea-hypopnea index (5, 5 to 40,
nd 40) and body mass index (25, 25 to 30, and 30
g/m2). Also, to evaluate whether greater follow-up in
atients with OSA could account for increased identifica-
ion of AF in these patients, we performed linear regression
nalyses to identify an association between follow-up dura-
ion and the apnea-hypopnea index, and to compare
ollow-up duration in patients without OSA and patients
ith increasing severities of OSA.
Analyses were performed using SAS Proprietary Software
elease 8.2 (1999 to 2000, SAS Institute, Cary, North
arolina). A 2-sided p value 0.05 was considered statis-
ically significant for all analyses. The authors had full access
o the data and take responsibility for its integrity; all
uthors have read and agree to the article as written.
esults
tudy population. The study population consisted of
,542 subjects, and their baseline characteristics are de- wcribed in Table 1. Obstructive sleep apnea (defined by an
pnea-hypopnea index 5) was present in 2,626 subjects
74%), and their mean apnea-hypopnea index was 36 (32),
ean awake oxygen saturation was 96% (3%), mean
octurnal oxygen saturation was 93% (4%), and lowest
octurnal oxygen saturation was 81% (11%). Use of
ontinuous positive airway pressure was reported for 123
f 695 (18%), 190 of 636 (30%), 253 of 648 (39%), and 338
f 647 (52%) subjects with increasing severity of OSA based
n quartiles of the apnea-hypopnea index. Bivariate linear
egression showed no association between follow-up time
nd the apnea-hypopnea index (p  0.87). Follow-up
uration was similar for patients without OSA (4.76 years)
nd for patients with increasing severities of OSA based on
uartiles of the apnea-hypopnea index (4.66 vs. 4.79 vs. 4.50
s. 4.59 years; analysis of variance p  0.58).
ncidence of AF. After an average follow-up of 4.7 years
up to 15 years), incident AF occurred in 133 subjects
cumulative frequency 14%, 95% confidence interval [CI]
% to 19%). Clinical characteristics and sleep measure-
ents that predicted incident AF are listed in Table 2.
hese included established risk factors for AF, such as
ale gender, age, hypertension, coronary artery disease,
eart failure, and smoking. In addition, body mass index
trongly predicted incident AF (per 1 kg/m2, hazard ratio
HR] 1.03, 95% CI 1.02 to 1.05, p  0.001). Further-
ore, OSA (defined by an apnea-hypopnea index 5)
aseline Characteristics of Patients
Table 1 Baseline Characteristics of Patients
Characteristic Value
Age, mean (SD), yrs 49 (14)
Male gender, n (%) 2,349 (66)
Body mass index, mean (SD), kg/m2 33 (9)
Coronary artery disease, n (%) 342 (10)
Heart failure, n (%) 89 (3)
Hypertension, n (%) 1,178 (33)
Diabetes mellitus, n (%) 397 (11)
History of smoking, n (%) 1,798 (56)
Obstructive sleep apnea, n (%) 2,626 (74)
Lowest nocturnal oxygen saturation, %
Mean (SD) 83 (10)
Median 87
Mean nocturnal oxygen saturation, %
Mean (SD) 93 (5)
Median 94
Decrease in nocturnal oxygen saturation,* %
Mean (SD) 12 (10)
Median 9
Apnea–hypopnea index, events/h
Mean (SD) 26.7 (31.3)
Median 15.0
Arousal index, events/h
Mean (SD) 35.4 (26.1)
Median 28.0
This variable is defined as the difference between awake oxygen saturation and mean nocturnal
xygen saturation.as a strong predictor of incident AF (HR 2.18, 95% CI
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OSA, Obesity, and AF February 6, 2007:565–71.34 to 3.54, p  0.002). Atrial fibrillation occurred in
14 of 2,626 patients (4.3%) with OSA and in 19 of 916
atients (2.1%) without OSA. Measures of OSA severity
ere also strong predictors of incident AF: the log of the
pnea-hypopnea index (p  0.001), tertiles of the apnea-
ypopnea index (p  0.001), log of the arousal index (p
0.001), log of the lowest nocturnal oxygen saturation
p  0.001), and log of the mean nocturnal oxygen
aturation (p  0.05).
Figure 1 Incidence of AF Based on Presence or Absence of OS
Cumulative frequency curves for incident atrial fibrillation (AF) for subjects 65 ye
and without obstructive sleep apnea (OSA) during an average 4.7 years of follow-u
isk of Incident Atrial Fibrillation, Univariate Model
Table 2 Risk of Incident Atrial Fibrillation, Univariate Model
HR 95% CI p Value
Age (per 10 yrs) 2.11 1.85–2.41 0.001
Male gender 1.86 1.22–2.85 0.004
Hypertension 2.85 2.02–4.02 0.001
Coronary artery disease 5.15 3.56–7.44 0.001
Heart failure 11.76 7.6–18.20 0.001
History of smoking 1.82 1.24–2.66 0.002
Diabetes mellitus 2.50 1.66–3.78 0.001
Body mass index (per 1 kg/m2) 1.03 1.02–1.05 0.001
Obstructive sleep apnea
(apnea–hypopnea index 5)
2.18 1.34–3.54 0.002
Apnea–hypopnea index (per 1 event/h)* 1.31 1.14–1.50 0.0001
Tertiles of apnea–hypopnea index
distribution
1.36 1.13–1.64 0.001
Arousal index (per 1 event/h)* 1.65 1.29–2.10 0.001
Lowest nocturnal oxygen saturation
(per 1%)*
3.08 1.72–5.54 0.001
Mean nocturnal oxygen saturation
(per 1%)†
1.30 2.82–4.77 0.05
For a 1-U change in the logarithm. †For a 0.1-U decrease in the logarithm.
CI  confidence interval; HR  hazard ratio.ge-stratified, multivariate analyses. The regression
odels showed a significant interaction between OSA and
ge (p  0.04). This was consistent with previous data
howing that age modifies the effect of OSA on cardiovas-
ular outcomes, such that cardiovascular effects of OSA
anifest in individuals younger than about age 65, but not
n those who are older (27,28). These considerations pro-
ided the rationale for stratified analyses for subjects
ounger than 65 years (3,053 of 3,542, 86%) and 65 years or
lder (489 of 3,542, 14%). The cumulative probability of
ncident AF was significantly greater for subjects 65 years of
ge with OSA compared with those without OSA (Fig. 1).
he results of multivariate Cox proportional hazards regres-
ion for subjects65 years of age and for subjects65 years
f age are shown in Table 3. In subjects 65 years of age,
stablished risk factors for AF (age, male gender, and
oronary artery disease) independently predicted incident
F, as did body mass index (per 1 kg/m2, HR 1.07, 95% CI
.05 to 1.10, p  0.001). The decrease in nocturnal oxygen
aturation also was an independent predictor of incident AF
for each 0.5-U change in the log, HR 3.29, 95% CI 1.35 to
.04, p  0.009). For subjects 65 years old, only heart
ailure independently predicted incident AF (HR 7.68, 95%
I 4.32 to 13.66, p  0.001). In a multivariate regression
odel that included only subjects with OSA, use of con-
inuous positive airway pressure did not positively or nega-
ively affect the incidence of AF. In multivariate regression
odels that directly compared the effects of OSA and
besity on incident AF, the conditions significantly pre-
icted incident AF independently of each other (Fig. 2).
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February 6, 2007:565–71 OSA, Obesity, and AFiscussion
his large cohort study provides important insights into the
elationships between obesity, OSA, and AF. First, it
onfirms recent data showing that obesity is an independent
isk factor for incident AF (5,6). It extends this information
ith the novel finding that body mass index predicts
ncident AF independently of OSA. Furthermore, the study
as shown for the first time that in individuals 65 years of
ge, OSA strongly predicts the incidence of AF within
bout 5 years of its diagnosis, and that the degree of
octurnal oxygen desaturation, which is an important
athophysiological consequence of OSA, independently
orrelates with the risk of incident AF.
Although recent studies showed an independent role of
besity in predicting AF (5,6), other data suggest that this
elationship may not be evident in older patients (i.e., those
65 years of age) (29,30). In this context, the findings in
ur select population suggest that the mechanisms by which
besity confers risk of AF may be more significant during
ounger adult ages. In these individuals, for every increase of
kg/m2 (e.g., moving from normal weight to overweight, or
rom overweight to mild obesity), the risk of incident AF
ncreased by 15%.
Similar differential effects of age on incident AF risk were
vident for OSA. The limitation of the predictive power of
SA to adults 65 years of age is consistent with previous
tudies of OSA and cardiovascular morbidity and mortality
27,28), which together suggest that the pathophysiological
onsequences of OSA are less striking in older adults, in
hom other factors may have greater prognostic signifi-
ance. Why OSA and obesity may be accompanied by an
ncreased risk of incident AF in individuals65 years of age
ut not in older persons is unclear. Obesity and OSA are
ikely to be present and established by middle age. It is
ossible that when obesity and/or OSA are diagnosed at age
5 years or older, both conditions would already have been
resent for many years before diagnosis, and any effect on
he incidence of AF already would be manifest. Subjects
ith AF at the time of diagnosis of OSA were excluded
isk of Incident Atrialibrillation, Multivariate Models
Table 3 Risk of Incident AtrialFibrillation, Multivariate Models
HR 95% CI p Value
65 yrs old
Age (per 10 yrs) 2.04 1.48–2.80 0.001
Male gender 2.66 1.33–5.30 0.006
Coronary artery disease 2.66 1.46–4.83 0.001
Body mass index (per 1 kg/m2) 1.07 1.05–1.10 0.001
Decrease in nocturnal oxygen
saturation (per 1%)*
3.29 1.35–8.04 0.009
65 yrs old
Heart failure 7.68 4.32–13.66 0.001
For a 0.5-U change in the logarithm of the difference between awake oxygen saturation andmean
octurnal oxygen saturation.
CI  confidence interval; HR  hazard ratio.rom our study—it is possible that if the effects of obesitynd OSA had not already led to AF by the age of 65, then
hey were unlikely to do so as these older patients aged.
It is crucial for studies of obesity and cardiovascular risk
o identify OSA in the study populations because several
ardiovascular disease mechanisms in obese people can also
e attributable to occult OSA (10–14). Although relation-
hips between obesity and AF have been explored, no prior
tudy incorporated the presence or absence of OSA into
redictive models for AF during long-term follow-up.
herefore, it remained unclear whether OSA was con-
ounding relationships between obesity and AF. In the
resent study, we were able to classify the presence or
bsence of OSA based on the gold standard diagnostic test,
olysomnography, in a large study population. That obesity
emains a powerful predictor of incident AF, even after
ontrolling for OSA, in people 65 years of age clarifies an
mportant question raised by previous studies (8).
Our finding that the magnitude of the decrease in
octurnal oxygen saturation was independently predictive of
ncident AF may provide insight into the putative mecha-
isms that link OSA to the development of AF. The
rimary consequence of an apnea is hypoxemia, which
irectly or indirectly (by promoting ischemia, sympathetic
ctivation, and inflammation) may be an important mech-
nistic link to cardiovascular complications. Indeed, previ-
us investigations have implicated measures of oxygen
esaturation as likely mediators of the interaction between
SA and AF. One study found a direct relationship
etween incident AF and the oxygen desaturation index, but
ot the apnea-hypopnea index, before hospital discharge in
atients undergoing coronary bypass surgery (31). A second
tudy found that a very high rate of recurrent AF after
lectrical cardioversion in patients with untreated OSA was
Figure 2 Incidence of AF Based on the
Severity of OSA and Obesity
Cumulative frequency of incident atrial fibrillation (AF) during an average 4.7
years of follow-up, based on interactions between the body mass index (BMI)
and the apnea-hypopnea index (AHI). An AHI 5 represents no obstructive
sleep apnea (OSA), an AHI 5 to 40 represents mild to moderate OSA, and an
AHI 40 represents severe OSA. A BMI 25 represents normal weight, a BMI
25 to 30 kg/m2 represents overweight, and a BMI 30 kg/m2 represents
obesity.
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OSA, Obesity, and AF February 6, 2007:565–71irectly related to the magnitude and duration of nocturnal
xygen desaturation (32). Our findings are consistent with
his literature. Identification of the specific mechanisms that
nitiate or promote AF in OSA patients may have implica-
ions for targeted intervention strategies.
Multiple studies have described the independent associ-
tion of OSA with diastolic dysfunction (19–22). The
attern of mitral early and late inflow velocities (E-A ratio)
nd the duration of mitral early inflow (deceleration time)
ere both shown to correlate with the magnitude and
uration of oxygen desaturation during sleep in OSA
atients (19–22). Diastolic dysfunction may lead to in-
reases in left atrial size, which has been shown to power-
ully predict incident AF (29). Left atrial size also may be
ncreased in OSA patients because of stretch of the thin-
alled atria during the repetitive Mueller maneuvers (at-
empted inspirations against the obstructed airway) that
haracterize obstructive apneic sleep. These obstructed in-
pirations generate wide fluctuations in negative intratho-
acic pressure, which elicit changes in cardiac transmural
ressures and increased cardiac wall stress (15–17). Thus,
echanisms by which OSA increases the risk of AF may
nclude diastolic dysfunction and increased left atrial size.
owever, the present study cannot address this directly.
Other mechanisms may also contribute to the increased
isk of AF in people with OSA. Rapid swings in cardiac
ransmural pressures may activate atrial stretch-sensitive ion
hannels, particularly in anatomically vulnerable sites such
s the pulmonary vein ostia, that are implicated in the
nitiation of AF. Another potential mechanism is the marked
utonomic imbalance that occurs in OSA (18). The severe
levations of sympathetic activity during apneas may activate
trial catecholamine-sensitive ion channels and result in
ocal discharges that initiate AF. Furthermore, the marked
agal predominance at the end of apneas, which is associ-
ted with bradyarrhythmias, may change conduction prop-
rties of the atria to promote AF. Lastly, OSA is associated
ith systemic inflammation (14), which may increase the
isk of AF via effects on atrial myocardial remodeling (33).
The finding that the use of continuous positive airway
ressure did not reduce the risk of AF deserves mention.
he method by which we classified use of continuous
ositive airway pressure was limited because of the retro-
pective nature of the study. The assessment relied on the
ubjective reporting of continuous positive airway pressure
se and the documentation of such in the medical record. It
ould not account for its frequency (days per week or hours
er night) of use, compliance, or effectiveness at abolishing
pneas because the majority of subjects were cared for before
he widespread use of continuous positive airway pressure
evices that incorporate time-of-use counters. Intuitively,
he use of continuous positive airway pressure, which
ecreases apneic events and reduces hypoxemia, would be
xpected to protect from incident AF. However, continuous
ositive airway pressure tends to be prescribed and used
ore often in patients with more severe OSA, as was also avident in our study. Thus, patients with more severe OSA
ere more likely to be using continuous positive airway
ressure therapy, which may have confounded the associa-
ion between its use and incident AF. This is especially true
ecause compliance with and effectiveness of the treatment
ould not be assessed and accounted for in the predictive
odels.
A limitation of the study is that the sample consisted of
atients referred to a sleep clinic because of a suspected sleep
isorder. Extending the findings to the general population is
imited by the fact that characteristics of OSA in the general
opulation may differ from those in this referral population.
owever, there are major economic and logistic obstacles to
onfirming the diagnosis of OSA with the gold standard
est, polysomnography, in large population studies. Thus,
valuating the questions assessed in the present study in the
opulation at large is limited by resources and only rarely
ossible. In fact, over 80% of individuals with OSA in the
eneral population remain undiagnosed (34). Another lim-
tation is the method of ascertainment of AF during
ollow-up, which would fail to identify patients with asymp-
omatic AF who did not seek medical attention. This is a
ommon limitation in studies of AF, even in prospective
tudies that use electrocardiographic monitoring. Ours was
retrospective cohort study, and thus active electrocardio-
raphic monitoring of study patients to identify incident AF
as not possible. We limited our study sample to individuals
ho were Olmsted County residents to form a geographi-
ally circumscribed group of patients whose medical
ollow-up would be limited mostly to our institution. The
etails of the Mayo Medical Index were described earlier,
nd this system should have been successful in including all
iagnosed episodes of AF during follow-up. Another poten-
ial limitation of the study is that the presence of OSA may
ave resulted in greater follow-up, which could have led to
ncreased identification of AF in OSA patients. To address
his, we compared follow-up durations in these patients and
ound that follow-up duration was unrelated to the presence
r severity of OSA. However, it remains possible that
atients with OSA had more medical encounters than
atients without OSA despite similar follow-up durations.
astly, there is the consideration that the risk of AF was
odified during follow-up by the progression of obesity and
evelopment of OSA after an initially negative polysomno-
ram. It is possible that individuals without OSA at the
ime of polysomnography gained weight during follow-up
nd developed OSA, which if true in a substantial propor-
ion of study patients could have limited our ability to
dentify more robust associations between OSA and AF.
onclusions. In this cohort of 3,542 people who under-
ent complete polysomnography, obesity, and the magni-
ude of nocturnal oxygen desaturation, which is an impor-
ant pathophysiological consequence of OSA, were
ndependent risk factors for incident AF over an average of
bout 5 years of follow-up. The risks conferred by obesity
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February 6, 2007:565–71 OSA, Obesity, and AFnd OSA were independent of one another and limited to
eople 65 years of age.
Our results have important implications, first, for under-
tanding the pathophysiology of AF, and second, for the
rowing obesity epidemic, which is accompanied by a
ignificant increase in the number of individuals with OSA.
ased on our findings, both obesity and OSA may contrib-
te to the looming epidemic of AF. Both conditions should
e recognized as independent risk factors for incident AF.
reatments targeting obesity are imperative, and random-
zed controlled trials are required to evaluate the efficacy of
he treatment of OSA for preventing or treating AF.
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